Diffuse follicle center lymphoma, spleen
ICD-10 C82.57 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, spleen.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells within the follicle centers of lymphoid tissue. When localized to the spleen, it presents with splenomegaly and may be associated with systemic symptoms. DFCL is typically classified under the broader category of follicular lymphomas, which are known for their indolent course but can transform into more aggressive forms. Patients may exhibit B-symptoms, including fever, night sweats, and unexplained weight loss, which can indicate disease progression. Diagnosis is confirmed through histopathological examination and immunophenotyping, often requiring a biopsy of the spleen or affected lymph nodes. Treatment options vary based on the stage of the disease and may include watchful waiting, chemotherapy, immunotherapy, or splenectomy. The prognosis depends on various factors, including the patient's overall health, age, and the presence of B-symptoms.
Detailed clinical notes on symptoms, staging, and treatment plans.
Diagnosis and management of lymphoma, treatment response assessments.
Ensure accurate documentation of histopathological findings and treatment regimens.
Comprehensive reports on biopsy results and immunophenotyping.
Histological evaluation of lymphoid tissues, differential diagnosis of lymphomas.
Clear communication of findings to referring physicians for accurate coding.
Used when a biopsy is performed to confirm diagnosis of C82.57.
Pathology report detailing histological findings.
Pathologists must ensure accurate coding based on findings.
Common treatments include chemotherapy, immunotherapy, and in some cases, splenectomy. The choice of treatment depends on the stage of the disease and the presence of symptoms.
